Silverarc Capital Management

Latest statistics and disclosures from Silverarc Capital Management's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Silverarc Capital Management

Companies in the Silverarc Capital Management portfolio as of the March 2022 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Spdr Ser Tr S&p Biotech Call Option (XBI) 11.2 $27M NEW 300k 89.88
Athira Pharma (ATHA) 11.2 $27M -90% 10k 2696.40
Intra Cellular Therapies (ITCI) 7.8 $19M +203% 309k 61.19
Sierra Oncology Com New (SRRA) 5.9 $14M +171% 443k 32.05
Veracyte (VCYT) 4.9 $12M +137% 426k 27.57
Cti Biopharma (CTIC) 4.3 $11M NEW 2.3M 4.67
Merus N V (MRUS) 3.6 $8.6M -6% 325k 26.44
Cerus Corporation (CERS) 3.2 $7.7M +125% 1.4M 5.49
Horizon Therapeutics Pub L SHS (HZNP) 2.9 $7.1M +28% 67k 105.22
Apollo Endosurgery (APEN) 2.5 $6.1M NEW 1.0M 6.05
Apellis Pharmaceuticals (APLS) 2.2 $5.4M NEW 105k 50.81
Aclaris Therapeutics (ACRS) 2.0 $4.7M +58% 275k 17.24
ImmunoGen Call Option (IMGN) 1.9 $4.5M +45% 945k 4.76
Iteos Therapeutics (ITOS) 1.8 $4.5M +18% 139k 32.18

Setup an alert

Silverarc Capital Management will file the next quarterly 13-HR in about 3 months. Would you like to be notified?

Biohaven Pharmaceutical Holding (BHVN) 1.8 $4.4M +65% 103k 42.53
Cogent Biosciences (COGT) 1.8 $4.3M -15% 574k 7.49
Mirati Therapeutics (MRTX) 1.6 $3.8M 46k 82.22
Immatics SHS (IMTX) 1.5 $3.6M 445k 7.99
Krystal Biotech (KRYS) 1.3 $3.1M NEW 47k 66.53
Ngm Biopharmaceuticals (NGM) 1.3 $3.1M NEW 201k 15.25
Otonomy (OTIC) 1.2 $2.9M +18% 1.2M 2.40
Morphic Hldg (MORF) 1.1 $2.8M +19% 69k 40.15
United Therapeutics Corporation (UTHR) 1.1 $2.7M -29% 15k 179.43
Galapagos Nv Spon Adr (GLPG) 1.1 $2.5M NEW 41k 62.02
Crinetics Pharmaceuticals In (CRNX) 1.0 $2.5M +130% 114k 21.95
Insmed Com Par $.01 (INSM) 1.0 $2.4M -41% 102k 23.50
Miragen Therapeutics (VRDN) 1.0 $2.3M +18% 126k 18.49
Seres Therapeutics (MCRB) 1.0 $2.3M +18% 327k 7.12
Eyepoint Pharmaceuticals Com New (EYPT) 0.9 $2.3M +43% 186k 12.15
Vertex Pharmaceuticals Incorporated (VRTX) 0.8 $2.0M NEW 7.6k 260.93
Neurocrine Biosciences (NBIX) 0.8 $1.9M NEW 21k 93.74
Leap Therapeutics (LPTX) 0.7 $1.8M +66% 1.0M 1.75
Syndax Pharmaceuticals (SNDX) 0.7 $1.8M NEW 101k 17.38
Viewray (VRAY) 0.7 $1.7M +135% 436k 3.92
Jounce Therapeutics (JNCE) 0.7 $1.7M +19% 248k 6.79
Codexis (CDXS) 0.7 $1.7M NEW 81k 20.62
Point Biopharma Global (PNT) 0.7 $1.6M +185% 205k 7.97
Forma Therapeutics Hldgs SHS (FMTX) 0.7 $1.6M NEW 175k 9.30
Iveric Bio Put Option (ISEE) 0.7 $1.6M +215% 95k 16.83
Aslan Pharmaceuticals Ads (ASLN) 0.7 $1.6M NEW 500k 3.18
Seagen (SGEN) 0.7 $1.6M -6% 11k 144.03
Xenon Pharmaceuticals (XENE) 0.6 $1.4M +420% 101k 14.13
Ascendis Pharma A/s Sponsored Adr (ASND) 0.6 $1.4M NEW 25k 57.12
Cyclacel Pharmaceuticals (CYCC) 0.6 $1.4M +19% 463k 3.05
Stereotaxis Com New (STXS) 0.5 $1.3M +18% 346k 3.73
Medicus Sciences Acquisition Cl A Shs (MSAC) 0.5 $1.3M +19% 131k 9.78
Amryt Pharma Sponsored Ads (AMYT) 0.5 $1.3M -70% 153k 8.27
Polypid SHS (PYPD) 0.5 $1.2M +19% 218k 5.46
Lucira Health (LHDX) 0.5 $1.1M +40% 311k 3.57
Eloxx Pharmaceuticals (ELOX) 0.5 $1.1M +54% 2.0M 0.56
Poseida Therapeutics I (PSTX) 0.4 $1.1M NEW 240k 4.48
Nextcure (NXTC) 0.4 $953k -72% 196k 4.86
Compugen Ord (CGEN) 0.4 $865k -40% 269k 3.22
Immunic (IMUX) 0.3 $774k NEW 69k 11.30
Eliem Therapeutics (ELYM) 0.3 $741k NEW 88k 8.39
Aptinyx Put Option (APTX) 0.2 $458k NEW 202k 2.27
Amylyx Pharmaceuticals 0.2 $386k NEW 30k 12.87
Evogene SHS (EVGN) 0.2 $384k +19% 296k 1.30
Mereo Biopharma Group Ads (MREO) 0.1 $264k -35% 236k 1.12
Celldex Therapeutics Com New (CLDX) 0.1 $256k +19% 46k 5.62
Biogen Idec (BIIB) 0.1 $230k +133% 10k 22.44
BioCryst Pharmaceuticals (BCRX) 0.1 $197k NEW 102k 1.92
Bellus Health Com New (BLU) 0.1 $177k +238% 1.2M 0.14
Calithera Biosciences (CALA) 0.0 $74k +19% 222k 0.33
Benitec Biopharma (BNTC) 0.0 $57k 493k 0.12
Renovacor *w Exp 99/99/999 (RCOR.WS) 0.0 $33k 105k 0.31
Aligos Therapeutics (ALGS) 0.0 $23k NEW 11k 2.16
Medicus Sciences Acquisition *w Exp 02/12/202 (MSACW) 0.0 $21k 50k 0.42

Past Filings by Silverarc Capital Management

SEC 13F filings are viewable for Silverarc Capital Management going back to 2020